California, USA- March 2024- MENADNA Inc. proudly announces an exclusive partnership with Nebula Genomics, a trailblazer in personalized genome sequencing. This pivotal collaboration designates MENADNA as the exclusive partner of Nebula Genomics in Jordan, Oman, and Iraq. MENADNA currently operates in the UAE and has plans to expand into the Saudi market in the future.

However, This partnership, spearheaded by MENADNA’s CEO, Dr. Bassam El Fahmawi, aims to bridge the significant gap in genomic testing within Jordan, Oman, and Iraq. By harnessing Nebula Genomics’ advanced sequencing technologies alongside MENADNA’s proprietary bioinformatics pipeline, the alliance aims to significantly improve the quality and relevance of genomic data for the region, historically underserved in global genome-wide association studies (GWAS).

Partnership Highlights:

Exclusive Partnership: MENADNA positions itself as Nebula Genomics’ exclusive partner in Jordan, Oman, and Iraq, encompassing a population of over 56 million people. This partnership will empower the region’s healthcare system with advanced Whole Genome Sequencing services for individuals and families.

Bioinformatics Excellence: Utilizing MENADNA’s advanced bioinformatics pipeline, together with Nebula’s propriety reports, the partnership will refine and enhance genomic data quality, addressing the unique genetic makeup and health needs of the region.

Addressing the GWAS Gap: The region currently underrepresents a diverse genetic landscape in global GWAS, which predominantly features European ancestries. This collaboration aims to contribute valuable genomic data from this population, thereby enriching global genetic databases and research.

Also Read: Deep Health Information for Transformational Change in Democratizing Precision Medicine

Furthermore, Dr. Bassam El Fahmawi, CEO of MENADNA, shared his vision for the impact of this partnership: “Our collaboration with Nebula Genomics is a game-changer for genomic testing in Jordan, Oman, and Iraq. By combining Nebula’s state-of-the-art sequencing technology with our specialized bioinformatics pipeline, we can provide more accurate, region-specific genomic insights.’’

Jason Karkus, President of Nebula Genomics commented: “Nebula Genomics, a global pioneer in Whole Genome Sequencing is pleased to partner with MENADNA, bringing our cutting edge, low-cost technology, to Jordan, Oman, and Iraq. This is an exciting partnership, which we believe will lead to a substantial business relationship between our companies.’’